Counts and Characteristics of Pegylated Liposomal Doxorubicin and Non-Liposomal Doxorubicin Users: A Descriptive Analysis Read more about Counts and Characteristics of Pegylated Liposomal Doxorubicin and Non-Liposomal Doxorubicin Users: A Descriptive Analysis
Signal Detection and Refinement Activities within FDA’s Sentinel System Read more about Signal Detection and Refinement Activities within FDA’s Sentinel System
Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis Read more about Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis
Utilization, Dispensing, and Coding Patterns of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis Read more about Utilization, Dispensing, and Coding Patterns of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis
Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis Read more about Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis
Characterization of Cannabis-Derived Product Users in the National Patient-Centered Clinical Research Network (PCORnet): A Descriptive Analysis Read more about Characterization of Cannabis-Derived Product Users in the National Patient-Centered Clinical Research Network (PCORnet): A Descriptive Analysis
CHOC Tapped for Mental Health Expertise on National AI Project Involving Electronic Medical Records Read more about CHOC Tapped for Mental Health Expertise on National AI Project Involving Electronic Medical Records
Characterization of Use of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis Read more about Characterization of Use of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis
Preliminary Analysis of Drug Utilization Data to Inform the Development of the Pregnancy Safety Study Framework Read more about Preliminary Analysis of Drug Utilization Data to Inform the Development of the Pregnancy Safety Study Framework